An IVI RMA Research study wins the award for Best Paper at the ASRM 2025 Congress alongside Juno Genetics

IVI RMA, a group specialized in reproductive medicine, has announced that a joint research project with Juno Genetics, using data from the Foundation for Embryonic Competence and RMA New Jersey, has been awarded the Best Scientific Paper Award at the Annual Congress and Exhibition of the American Society for Reproductive Medicine (ASRM) 2025.

The study analyzed the reproductive potential of embryos with segmental aneuploidies, those in which chromosomal fragments are missing or abundant, in order to determine how many of them can lead to a birth, thus providing useful information for doctors and patients when interpreting the results of the preimplantation genetic testing for aneuploidies (PGT-A).

Three other IVI RMA studies were also recognized at the ASRM congress, placing the company among the winners of the first two awards for best papers, the second being for the best poster and the Special Interest Group (SIG) Nutrition Award. These studies addressed the need for greater standardization in preimplantation genetic testing, the impact of premature progesterone peaks during ovarian stimulation on IVF outcomes, and the role of nutritional interventions in fertility treatment outcomes.

Three of the four papers were led by physicians and specialists in specialized training from the Jefferson-RMA Fellowship program, associated with IVI RMA, which trains the next generation of reproductive endocrinologists. “This recognition from the industry is a testament to the cutting-edge nature of our research alongside partners like Juno, a world leader in embryonic genetic diagnosis, within our global network of research centers. Here, we address the most relevant issues in reproductive medicine with a scale and efficiency that are hard to match,” said Dr. Juan A. García-Velasco, Global Chief Scientific Officer of IVI RMA Global. “This award reinforces our commitment to science, which will make assisted reproductive medicine more effective and accessible for people and families around the world.”

With five international research centers, more than 500 clinical researchers, and over 240 peer-reviewed publications in 2024 alone, IVI RMA continues to lead scientific innovation in reproductive medicine with the goal of improving patient care. At this year's congress, more than 100 IVI RMA experts from five countries presented 65 scientific communications. “Juno Genetics is a world leader in evidence-based embryonic genetic testing (PGT) using the clinically validated PGTseq platform, and we are proud to present outcome data that help doctors and patients make informed decisions,” stated Chaim Jalas, CEO and Director of Technology Development at Juno Genetics.

The award-winning paper, titled 'Investigating the Reproductive Potential of Non-Mosaic Segmental Aneuploidy: A Double-Blinded, Multicenter Non-Selection Study Of 176 Single Frozen Embryo Transfers', was presented by Dr. Stephanie Willson, a physician from the IVI RMA Global Research Alliance and a graduate of the Jefferson-RMA Fellowship (class of 2025). Among the authors are Amber Kaplun (MS, IVI RMA America), David Ferrando, Yiping Zhan (PhD), Xin Tao (PhD), Emily Mounts (MS), Antonio Capalbo (PhD), Chaim Jalas (Juno Genetics), and Richard T. Scott (MD, Foundation for Embryonic Competence).

During the congress, it was also announced that Denny Sakkas, PhD, Scientific Director of Boston IVF, received the ASRM 2025 Distinguished Researcher Award, one of the most prestigious recognitions in reproductive medicine, for his pioneering research on sperm DNA damage, fertilization, early embryonic development, and male infertility.

“These ASRM recognitions reflect the innovation and teamwork that characterize IVI RMA's research in North America and around the world,” said Dr. Denny Sakkas, Scientific Director of Boston IVF. “Achievements like these are never the result of a single individual, but the outcome of a shared vision and the commitment of hundreds of experts working together to offer patients the greatest opportunities to start a family.”

“We are extremely proud that the research conducted by our physicians has been recognized among the best at this edition of ASRM,” added Dr. Marie Werner, Director of the Jefferson-RMA Fellowship in Reproductive Endocrinology and Infertility. “Our doctors Devika Sachdev, Stephanie Willson, and Andrés Reig perfectly represent our joint commitment to advancing evidence-based reproductive medicine focused on improving patient outcomes.”